Cargando…
Effective combined therapy with ramucirumab for advanced pulmonary pleomorphic carcinoma
Pulmonary pleomorphic carcinoma (PPC) is a rare disease with a poor prognosis. Most patients with PPC are refractory to chemotherapy, whereas good responses to platinum‐based chemotherapy in combination with the anti‐angiogenesis agent bevacizumab have been reported. An 82‐year‐old man was diagnosed...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161404/ https://www.ncbi.nlm.nih.gov/pubmed/30275953 http://dx.doi.org/10.1002/rcr2.372 |